93 related articles for article (PubMed ID: 1923954)
1. Effects of estrogens on pituitary cell and pituitary tumor growth.
Lloyd RV; Jin L; Fields K; Kulig E
Pathol Res Pract; 1991 Jun; 187(5):584-6. PubMed ID: 1923954
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
Maeda T; Lloyd RV
Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
[TBL] [Abstract][Full Text] [Related]
3. The effects of estrogens on tumor growth and on prolactin and growth hormone mRNA expression in rat pituitary tissues.
Lloyd RV; Cano M; Landefeld TD
Am J Pathol; 1988 Nov; 133(2):397-406. PubMed ID: 2461092
[TBL] [Abstract][Full Text] [Related]
4. Regulation of prolactin gene expression in a DMBA-estrogen-induced transplantable rat pituitary tumor.
Lloyd RV; Jin L; Fields K; Kulig E
Am J Pathol; 1990 Dec; 137(6):1525-37. PubMed ID: 2124415
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
Dembinski TC; Leung CK; Shiu RP
Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
[TBL] [Abstract][Full Text] [Related]
6. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.
Spady TJ; McComb RD; Shull JD
Endocrine; 1999 Dec; 11(3):217-33. PubMed ID: 10786818
[TBL] [Abstract][Full Text] [Related]
7. Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy.
Daniel L; Trouillas J; Renaud W; Chevallier P; Gouvernet J; Rougon G; Figarella-Branger D
Cancer Res; 2000 Jan; 60(1):80-5. PubMed ID: 10646857
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
Song JY; Jin L; Lloyd RV
Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
[TBL] [Abstract][Full Text] [Related]
9. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
[TBL] [Abstract][Full Text] [Related]
10. Transcription factors in normal and neoplastic pituitary tissues.
Lloyd RV; Osamura RY
Microsc Res Tech; 1997 Oct; 39(2):168-81. PubMed ID: 9361268
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
12. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
13. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
[TBL] [Abstract][Full Text] [Related]
14. Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors.
Lloyd RV; Landefeld TD; Maslar I; Frohman LA
Am J Pathol; 1985 Mar; 118(3):379-86. PubMed ID: 3976841
[TBL] [Abstract][Full Text] [Related]
15. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen-induced pituitary tumors--in relation to the changes in the pituitary gland after estrogen withdrawal].
Kojima M; Hashimoto N; Yamagami T; Handa H
No To Shinkei; 1985 Nov; 37(11):1087-93. PubMed ID: 4074580
[TBL] [Abstract][Full Text] [Related]
17. Differences between rat strains in the development of PRL-secreting pituitary tumors with long-term estrogen treatment: In vitro insulin-like growth factor-1-induced lactotroph proliferation and gene expression are affected in Wistar-Kyoto rats with low estrogen-susceptibility.
Mitsui T; Ishida M; Izawa M; Arita J
Endocr J; 2013; 60(11):1251-9. PubMed ID: 23985690
[TBL] [Abstract][Full Text] [Related]
18. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
19. [The role of central catecholamines and dopaminergic receptors in the development of estrogen-induced adenohypophyseal hypertrophy].
Pacák K; Nedvídková J
Cas Lek Cesk; 1995 May; 134(10):296-301. PubMed ID: 7788647
[TBL] [Abstract][Full Text] [Related]
20. [Recent progress in experimental pituitary tumors in various animals].
Ishii J; Kawakami Y
Nihon Rinsho; 1993 Oct; 51(10):2580-4. PubMed ID: 8254925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
